ERNA Financials
Eterna Therapeutics Inc - Financial statements & key metrics
Stock Price
$4.35
Market Cap
$6.87M
P/E Ratio
0.0
EPS
$56.32
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$582,000
Gross Profit
-
Operating Income
-
Net Income
$-44.54M
EPS (Diluted)
$-3.26
Balance Sheet Highlights
Total Assets
$5.27M
Total Liabilities
$3.57M
Shareholders Equity
-
Cash & Equivalents
$1.73M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-15.84M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Operating Margin
-992200.0%
ROE
-2264.3%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is ERNA revenue?
ERNA's most recent quarterly revenue was $582,000. Annual revenue can be calculated by summing the four most recent quarters.
Is ERNA profitable?
ERNA reported a loss of $44.54M in the most recent quarter.
What is ERNA market cap?
ERNA has a market capitalization of $6.87M, making it a small-cap stock.
Does ERNA have debt?
View ERNA's balance sheet for debt information.
What is ERNA cash flow?
Cash flow data is available in the full financial statements.